Yes, we must be vigilant to be certain that studies are run ethically and that results are published accurately and on time. But, to say that academic-industry relationships are full of “corruption” is both wrong and irresponsible.
Harvard Professor’s Attack On Pharma’s Clinical Trials Is Absurd
